NCT01198613View on ClinicalTrials.gov

ToleroMune Ragweed Exposure Chamber Study

PHASE2CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Ragweed Allergy
Interventions
BIOLOGICAL

ToleroMune Ragweed

Intradermal injection 1 x8 administrations 2 weeks apart

BIOLOGICAL

Placebo

Intradermal injection, 1x8 administrations 2 weeks apart

Trial Locations (2)

ON N6A 5R8

KGK Synergize Inc., London

L4W 1N2

Cetero Research, Mississauga

Sponsors
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Cetero Research, San Antonio

NETWORK

lead

Circassia Limited

INDUSTRY